Drug Trial Radar · NCT03569007
Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms
Last checked: Nov 19, 2026Latest source record: Jul 26, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
307
Actual
Start
May 29, 2019
Primary completion
Jul 21, 2022
Study completion Jul 21, 2022
Sponsor
- Lead sponsor
- 9 Meters Biopharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 26, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To assess the efficacy and safety of larazotide acetate versus placebo for the relief of persistent symptoms in adult celiac disease patients.
Conditions
- Celiac Disease
Interventions
LarazotideDrug
Synthetic 8-amino acid peptide formulated as enteric-coated beads in gelatin capsules
Matching PlaceboDrug
enteric-coated beads in gelatin capsules
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects who are binary respondersTime frame: 12 weeks
Locations
160 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Saraland, Alabama
Research Site
Scottsdale, Arizona
Research Site
Tucson, Arizona
Research Site
Tucson, Arizona
Research Site
North Little Rock, Arkansas
Research Site
Bellflower, California
Research Site
Beverly Hills, California
Research Site
Canoga Park, California
Research Site
Corona, California
Research Site
Garden Grove, California
Research Site
Lancaster, California
Research Site
Los Gatos, California
Research Site
Northridge, California
Research Site
Poway, California
Research Site
Rialto, California
Research Site
San Diego, California
Research Site
San Diego, California
Research Site
San Francisco, California
Research Site
Walnut Creek, California
Research Site
Bridgeport, Connecticut
Research Site
Bristol, Connecticut
Research Site
Hamden, Connecticut
Research Site
Stamford, Connecticut
Research Site
Boynton Beach, Florida
Research Site
Clearwater, Florida
Research Site
Inverness, Florida
Research Site
Lakewood Rch, Florida
Research Site
Miami, Florida
Research Site
Orange Park, Florida
Research Site
Orlando, Florida
Research Site
Orlando, Florida
Research Site
Port Orange, Florida
Research Site
Atlanta, Georgia
Research Site
Columbus, Georgia
Research Site
Macon, Georgia
Research Site
Stockbridge, Georgia
Research Site
Stone Mountain, Georgia
Research Site
Sugar Hill, Georgia
Research Site
Boise, Idaho
Research Site
Idaho Falls, Idaho
Showing 40 of 160 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.